Pharma's Patient Centricity
|出版日期||內容資訊||英文 45 Pages
|醫藥品產業的患者中心主義 Pharma's Patient Centricity|
|出版日期: 2016年02月08日||內容資訊: 英文 45 Pages||
Many in the industry agree that patient centricity is a business imperative, but it is unclear precisely what it means in business or organizational terms, and less clear still how to achieve it within the pharmaceutical industry. Patient centricity is not a function, but a mindset, a new way of doing R&D and of conceiving of therapeutic solutions.
There are multiple forces driving greater patient centricity. These include payers' focus on outcomes, the need for product differentiation, new digital technologies and data sources, advances in genomics and personalized medicines, and the empowered consumer. But there are as many hurdles, not least the lack of a roadmap as to how to be patient-centric, the lack of standards around patient-centric data and processes, regulatory uncertainties, disciplinary silos, and engrained attitudes clinging to traditional metrics and approaches to drug development.
This report addresses: